190 related articles for article (PubMed ID: 22380485)
1. Cystatin C is a strong predictor of survival in patients with cirrhosis: is a cystatin C-based MELD better?
Finkenstedt A; Dorn L; Edlinger M; Prokop W; Risch L; Griesmacher A; Graziadei I; Vogel W; Zoller H
Liver Int; 2012 Sep; 32(8):1211-6. PubMed ID: 22380485
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic value of the model for end-stage liver disease combined with serum sodium levels in patients with decompensated cirrhosis].
Li JY; Deng Q; Wang Y; Xu MY; Lu LG
Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):896-901. PubMed ID: 23522249
[TBL] [Abstract][Full Text] [Related]
3. Cystatin C is a good predictor of hepatorenal syndrome and survival in patients with cirrhosis who have normal serum creatinine levels.
Ahn HS; Kim YS; Kim SG; Kim HK; Min SK; Jeong SW; Jang JY; Lee SH; Kim HS; Kim BS; Park JM
Hepatogastroenterology; 2012 Jun; 59(116):1168-73. PubMed ID: 22057374
[TBL] [Abstract][Full Text] [Related]
4. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
Marroni CP; de Mello Brandão AB; Hennigen AW; Marroni C; Zanotelli ML; Cantisani G; Fuchs SC;
Clin Transplant; 2012; 26(4):E395-401. PubMed ID: 22882694
[TBL] [Abstract][Full Text] [Related]
5. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation.
Londoño MC; Cárdenas A; Guevara M; Quintó L; de Las Heras D; Navasa M; Rimola A; Garcia-Valdecasas JC; Arroyo V; Ginès P
Gut; 2007 Sep; 56(9):1283-90. PubMed ID: 17452425
[TBL] [Abstract][Full Text] [Related]
6. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
Giannini E; Botta F; Fumagalli A; Malfatti F; Testa E; Chiarbonello B; Polegato S; Bellotti M; Milazzo S; Borgonovo G; Testa R
Liver Int; 2004 Oct; 24(5):465-70. PubMed ID: 15482344
[TBL] [Abstract][Full Text] [Related]
7. Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score.
Francoz C; Prié D; Abdelrazek W; Moreau R; Mandot A; Belghiti J; Valla D; Durand F
Liver Transpl; 2010 Oct; 16(10):1169-77. PubMed ID: 20879015
[TBL] [Abstract][Full Text] [Related]
8. Serum cystatin C in advanced liver cirrhosis and different stages of the hepatorenal syndrome.
Barakat M; Khalil M
Arab J Gastroenterol; 2011 Sep; 12(3):131-5. PubMed ID: 22055590
[TBL] [Abstract][Full Text] [Related]
9. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
Lv XH; Liu HB; Wang Y; Wang BY; Song M; Sun MJ
J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
[TBL] [Abstract][Full Text] [Related]
10. Serum sodium predicts mortality in patients listed for liver transplantation.
Biggins SW; Rodriguez HJ; Bacchetti P; Bass NM; Roberts JP; Terrault NA
Hepatology; 2005 Jan; 41(1):32-9. PubMed ID: 15690479
[TBL] [Abstract][Full Text] [Related]
11. Plasma copeptin, a possible prognostic marker in cirrhosis.
Moreno JP; Grandclement E; Monnet E; Clerc B; Agin A; Cervoni JP; Richou C; Vanlemmens C; Dritsas S; Dumoulin G; Di Martino V; Thevenot T
Liver Int; 2013 Jul; 33(6):843-51. PubMed ID: 23560938
[TBL] [Abstract][Full Text] [Related]
12. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery.
Assenza GE; Graham DA; Landzberg MJ; Valente AM; Singh MN; Bashir A; Fernandes S; Mortele KJ; Ukomadu C; Volpe M; Wu F
Heart; 2013 Apr; 99(7):491-6. PubMed ID: 23406689
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of increased serum creatinine concentration as predictor of short-term outcome in decompensated cirrhosis.
Serra MA; Puchades MJ; Rodríguez F; Escudero A; del Olmo JA; Wassel AH; Rodrigo JM
Scand J Gastroenterol; 2004 Nov; 39(11):1149-53. PubMed ID: 15545175
[TBL] [Abstract][Full Text] [Related]
14. Cystatin C in acute heart failure without advanced renal impairment.
Naruse H; Ishii J; Kawai T; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Matsui S; Nomura M; Hishida H; Ozaki Y
Am J Med; 2009 Jun; 122(6):566-73. PubMed ID: 19393984
[TBL] [Abstract][Full Text] [Related]
15. Comparison of hepatic venous pressure gradient and two models of end-stage liver disease for predicting the survival in patients with decompensated liver cirrhosis.
Suk KT; Kim CH; Park SH; Sung HT; Choi JY; Han KH; Hong SH; Kim DY; Yoon JH; Kim YS; Baik GH; Kim JB; Kim DJ
J Clin Gastroenterol; 2012; 46(10):880-6. PubMed ID: 22810110
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
[TBL] [Abstract][Full Text] [Related]
17. Creatinine- versus cystatine C-based equations in assessing the renal function of candidates for liver transplantation with cirrhosis.
De Souza V; Hadj-Aissa A; Dolomanova O; Rabilloud M; Rognant N; Lemoine S; Radenne S; Dumortier J; Chapuis-Cellier C; Beyerle F; Bon C; Iwaz J; Selistre L; Dubourg L
Hepatology; 2014 Apr; 59(4):1522-31. PubMed ID: 24123197
[TBL] [Abstract][Full Text] [Related]
18. Elevated soluble tumor necrosis factor receptor 75 concentrations identify patients with liver cirrhosis at risk of death.
Grünhage F; Rezori B; Neef M; Lammert F; Sauerbruch T; Spengler U; Reichel C
Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1255-62. PubMed ID: 18995216
[TBL] [Abstract][Full Text] [Related]
19. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
Huo TI; Lin HC; Hsia CY; Huang YH; Wu JC; Chiang JH; Chiou YY; Lui WY; Lee PC; Lee SD
Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
[TBL] [Abstract][Full Text] [Related]
20. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
Ferlitsch M; Reiberger T; Hoke M; Salzl P; Schwengerer B; Ulbrich G; Payer BA; Trauner M; Peck-Radosavljevic M; Ferlitsch A
Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
